The Co‐Crystal Approach to Improve the Exposure of a Water‐Insoluble Compound: AMG 517 Sorbic Acid Co‐Crystal Characterization and Pharmacokinetics
- 30 September 2008
- journal article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 97 (9), 3942-3956
- https://doi.org/10.1002/jps.21280
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Novel Vanilloid Receptor-1 Antagonists: 2. Structure−Activity Relationships of 4-Oxopyrimidines Leading to the Selection of a Clinical CandidateJournal of Medicinal Chemistry, 2007
- Solid-State Acid−Base Interactions in Complexes of Heterocyclic Bases with Dicarboxylic Acids: Crystallography, Hydrogen Bond Analysis, and 15N NMR SpectroscopyJournal of the American Chemical Society, 2006
- Pharmaceutical Co-CrystalsJournal of Pharmaceutical Sciences, 2006
- Crystal Engineering Approach To Forming Cocrystals of Amine Hydrochlorides with Organic Acids. Molecular Complexes of Fluoxetine Hydrochloride with Benzoic, Succinic, and Fumaric AcidsJournal of the American Chemical Society, 2004
- Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?Chemical Communications, 2004
- Crystal and co-crystal: a second opinionCrystEngComm, 2003
- Molecular mechanisms of nociceptionNature, 2001
- In Situ Salt Screening-A Useful Technique for Discovery Support and Preformulation StudiesPharmaceutical Development and Technology, 1998
- Molecular Self-Assembly in the Solid State. The Combined Use of Solid-State NMR and Differential Scanning Calorimetry for the Determination of Phase ConstitutionChemistry of Materials, 1994
- XCVI.—Halogen derivatives of quinone. Part III. Derivatives of quinhydroneJournal of the Chemical Society, Transactions, 1893